Skip to main content
Livermore
Livermore
ZHEN

Elicio Therapeutics, Inc.

ELTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001601485

No open-market purchases or sales by Elicio Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $15.3M in total; no superinvestor holds it.

13F holders, Q1 2022

Institutional positions in Elicio Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
47
−6 vs. Q4 2021
Shares held
6.53M
−484.6K (−6.9%) vs. Q4 2021
Total value
$13.8M
−$6.48M (−31.9%) vs. Q4 2021
New holders
6
7 more added
Sold out
12
19 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ELTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 47 institutions
Q1 2021: 41 institutionsQ2 2021: 41 institutionsQ3 2021: 47 institutionsQ4 2021: 53 institutionsQ1 2022: 47 institutionsQ2 2022: 43 institutionsQ3 2022: 38 institutionsQ4 2022: 30 institutionsQ1 2023: 28 institutionsQ2 2023: 15 institutionsQ3 2023: 18 institutionsQ4 2023: 18 institutionsQ1 2024: 18 institutionsQ2 2024: 20 institutionsQ3 2024: 18 institutionsQ4 2024: 17 institutionsQ1 2025: 24 institutionsQ2 2025: 21 institutionsQ3 2025: 28 institutionsQ4 2025: 37 institutionsQ1 2026: 47 institutionsQ2 2026: 48 institutions
Value heldQ1 2022: $13.8M
Q1 2021: $92.0MQ2 2021: $66.5MQ3 2021: $69.3MQ4 2021: $20.3MQ1 2022: $13.8MQ2 2022: $5.90MQ3 2022: $4.71MQ4 2022: $3.98MQ1 2023: $2.56MQ2 2023: $2.71MQ3 2023: $2.80MQ4 2023: $2.78MQ1 2024: $3.08MQ2 2024: $2.68MQ3 2024: $2.48MQ4 2024: $2.25MQ1 2025: $9.80MQ2 2025: $11.2MQ3 2025: $20.9MQ4 2025: $16.6MQ1 2026: $28.2MQ2 2026: $15.3M
Institutions holding ELTX and their total value by quarter
QuarterHoldersValue
Q2 202648$15.3M
Q1 202647$28.2M
Q4 202537$16.6M
Q3 202528$20.9M
Q2 202521$11.2M
Q1 202524$9.80M
Q4 202417$2.25M
Q3 202418$2.48M
Q2 202420$2.68M
Q1 202418$3.08M
Q4 202318$2.78M
Q3 202318$2.80M
Q2 202315$2.71M
Q1 202328$2.56M
Q4 202230$3.98M
Q3 202238$4.71M
Q2 202243$5.90M
Q1 202247$13.8M
Q4 202153$20.3M
Q3 202147$69.3M
Q2 202141$66.5M
Q1 202141$92.0M

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Elicio Therapeutics, Inc.; share changes are against Q4 2021.

Institutions holding ELTX in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Nantahala Capital Management, LLC1,173,162$2.49M0.17%−93,867−7.4%Reduced
BVF Inc1,071,297$2.27M0.09%00.0%Unchanged
BlackRock Inc.1,008,657$2.14M0.00%−13,670−1.3%Reduced
Vanguard Group Inc634,843$1.35M0.00%−268,290−29.7%Reduced
CM Management, LLC450,000$954.0K0.80%+338,220+302.6%Added
Lake Street Advisors Group, LLC246,904$523.0K0.03%00.0%Unchanged
Geode Capital Management, LLC245,875$521.0K0.00%+21,222+9.4%Added
Renaissance Technologies LLC223,700$474.0K0.00%+32,600+17.1%Added
State Street Corp205,487$436.0K0.00%−21,226−9.4%Reduced
Northern Trust Corp169,587$360.0K0.00%−8,069−4.5%Reduced
JPMorgan Chase & Co141,848$300.0K0.00%−3,354−2.3%Reduced
Morgan Stanley125,226$266.0K0.00%−36,008−22.3%Reduced
Bridgeway Capital Management, LLC125,000$265.0K0.01%+125,000New
D. E. Shaw & Co., Inc.76,013$161.0K0.00%−17,126−18.4%Reduced
Valeo Financial Advisors, LLC63,659$135.0K0.01%+40,008+169.2%Added
Bank of America Corp63,436$134.0K0.00%−3,770−5.6%Reduced
Knoll Capital Management, LLC60,000$127.0K0.08%00.0%Unchanged
BLB&B Advisors, LLC56,847$121.0K0.01%00.0%Unchanged
Birchview Capital, LP54,392$115.0K0.08%00.0%Unchanged
Charles Schwab Investment Management Inc45,754$97.0K0.00%00.0%Unchanged
Bank of New York Mellon Corp43,092$91.0K0.00%00.0%Unchanged
Patriot Financial Group Insurance Agency, LLC33,500$71.0K0.01%+33,500New
Nuveen Asset Management, LLC32,142$69.0K0.00%00.0%Unchanged
STRS Ohio19,600$41.0K0.00%00.0%Unchanged
CAPROCK Group, Inc.15,726$33.0K0.00%00.0%Unchanged
Steward Partners Investment Advisory, LLC15,558$33.0K0.00%00.0%Unchanged
Deutsche Bank AG13,491$29.0K0.00%−1,398−9.4%Reduced
Acadian Asset Management LLC13,673$28.0K0.00%00.0%Unchanged
Occudo Quantitative Strategies LP12,802$27.0K0.00%−899−6.6%Reduced
Rhumbline Advisers11,699$25.0K0.00%+752+6.9%Added
Two Sigma Investments, LP10,727$23.0K0.00%−83,208−88.6%Reduced
American International Group, Inc.10,807$23.0K0.00%−762−6.6%Reduced
California State Teachers Retirement System9,564$20.0K0.00%−2,192−18.6%Reduced
Citigroup Inc7,957$17.0K0.00%−1,356−14.6%Reduced
Barclays PLC7,152$15.0K0.00%+7,152New
New York State Common Retirement Fund5,893$12.0K0.00%−37−0.6%Reduced
Wells Fargo & Company4,958$10.0K0.00%−11,643−70.1%Reduced
Tower Research Capital LLC (TRC)4,639$10.0K0.00%+434+10.3%Added
Amalgamated Bank3,726$8.00K0.00%+3,726New
Amalgamated Financial Corp.3,726$8.00K0.00%+3,726New
Legal & General Group Plc2,265$5.00K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.2,333$5.00K0.00%00.0%Unchanged
Ameritas Investment Partners, Inc.1,669$4.00K0.00%00.0%Unchanged
Royal Bank of Canada1,337$3.00K0.00%−4,067−75.3%Reduced
FMR LLC980$2.00K0.00%+380+63.3%Added
UBS Group AG466$1.00K0.00%−8,071−94.5%Reduced
Federated Hermes, Inc.348$1.00K0.00%+348New
Russell Investments Group, Ltd.0$00.00%−248,092−100.0%Sold out
Millennium Management LLC0$00.00%−62,640−100.0%Sold out
Jacobs Levy Equity Management, Inc0$00.00%−45,239−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−41,800−100.0%Sold out
Aristides Capital LLC0$00.00%−35,142−100.0%Sold out
Jump Financial, LLC0$00.00%−31,500−100.0%Sold out
Walleye Capital LLC0$00.00%−14,130−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−11,410−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−10,718−100.0%Sold out
XTX Topco Ltd0$00.00%−10,059−100.0%Sold out
Point72 Hong Kong Ltd0$00.00%−1,879−100.0%Sold out
Ellevest, Inc.0$00.00%−28−100.0%Sold out